Longdom Conferences

Speaker

Oct 17-18, 2022    Miami, USA
5th International Conference on

Interventional Cardiology and Heart Failure

Benjamin W Cooper

Benjamin W Cooper

USA

Title: Pharmaceutical Atrial-Ventricular Optimization in Diastolic Dysfunction: A Clinical Concept Application of Materials Engineering to Myocardial Pathophysiology

Biography:

Benjamin Cooper is currently a medical resident at Aventura Hospital and Medical Center in Aventura, FL. Prior to starting medical school, He was a full-time Firefighter/Paramedic in Des Moines, Iowa. In addition, he worked at Iowa Heart Center as a Testing Paramedic for CT, Nuclear, and Ultrasound departments. He has been an American Heart Association Basic Life Support Instructor since 2007. Ben received his Doctor Osteopathic Medicine degree and Masters of Medical Science degree from Lake Erie College of Osteopathic Medicine.

Useful Links

News

AI predicts if -- and when -- someone will have cardiac arrest

2022-04-14 - 2022-04

A new artificial intelligence-based approach can predict, significantly more accurately than a doctor, if and when a patient could die of cardiac arrest. The technology, built on raw images of patient's diseased hearts and patient backgrounds, stands to revolutionize clinical decision making and increase survival from sudden and lethal cardiac arrhythmias, one of medicine's deadliest and most puzzling conditions.

Hold the salt: Study reveals how reducing sodium intake can help patients with heart failure

2022-04-14 - 2022-04

The largest randomized clinical trial to look at sodium reduction and heart failure has found that reducing salt intake does not lead to fewer emergency visits, hospitalizations or deaths for patients with heart failure. Researchers did find an improvement in symptoms such as swelling, fatigue and coughing, as well as better overall quality of life.

Experimental ‘gene silencing’ therapy reduces lipoprotein(a), an important risk factor of heart disease, by up to 98%

2022-04-14 - 2022-04

Findings from a phase 1 trial show that an experimental 'gene silencing' therapy reduced blood levels of lipoprotein(a), a key driver of heart disease risk, by up to 98%.

Researchers find new strategy for preventing clogged arteries

2022-04-14 - 2022-04

Revving up a process that slows down as we age may protect against atherosclerosis, a major cause of heart attacks and strokes. Scientists have successfully minimized artery-narrowing plaque in mice that would otherwise develop those lesions. The researchers did so by boosting chaperone-mediated autophagy (CMA), a cellular housekeeping process.

Good news for coffee lovers: Daily coffee may benefit the heart

2022-04-14 - 2022-04

Drinking coffee -- particularly two to three cups a day -- is not only associated with a lower risk of heart disease and dangerous heart rhythms but also with living longer, according to recent studies. These trends held true for both people with and without cardiovascular disease. Researchers said the analyses -- the largest to look at coffee's potential role in heart disease and death -- provide reassurance that coffee isn't tied to new or worsening heart disease and may actually be heart protective.

Creating an 'adult-like' mature human cardiac tissue

2022-08-11 - 2022-08

Researchers have developed a new cardiac cell-derived platform that closely mimics the human heart, unlocking potential for more thorough preclinical drug development and testing, and better modeling for cardiac diseases.

Genes involved in heart disease are similar across all populations, study finds

2022-08-03 - 2022-08

The genes involved in coronary heart disease, the most common form of heart disease, appear to be nearly the same for everyone, according to a new study.

Newsletter

© 2024 All Rights Reserved by Longdom